PT Ikapharmindo Putramas Tbk (ISX:IKPM) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Ikapharmindo Putramas Tbk Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

PT Ikapharmindo Putramas Tbk Business Description

Address Jalan Pulogadung Raya No 29, Kawasan Industri Pulogadung, Jakarta, IDN, 13930
PT Ikapharmindo Putramas Tbk is an Indonesian pharmaceutical and consumer health company headquartered in Jakarta. It manufactures and markets prescription medicines, over-the-counter drugs, nutraceuticals, professional hair care products, and baby care products, serving the Indonesian market through pharmacies, hospitals, and retail channels. The company operates through three reportable segments: non-pharma, pharma, and contract manufacturing, with the non-pharma segment generating the largest share of revenue. Its non-pharma business covers consumer health and personal care brands, while the pharma segment supplies prescription and OTC medicines. The contract manufacturing segment produces pharmaceutical and consumer health products for third parties. Revenue is derived from the sale of its own branded products and from manufacturing services provided to other companies. The company focuses on maintaining a diverse product portfolio for Indonesian consumers.